Mucosal immunoglobulins

Immunological Reviews

Volumn 206, Issue , 2005, Pages 64-82

  Woof, Jenny M ^a   Mestecky, Jiri ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; FC RECEPTOR; FC RECEPTOR ALPHA MUR; FC RECEPTOR ALPHARI; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN J CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY STRUCTURE; BIOSYNTHESIS; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MUCOSAL IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR BINDING; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULINS; MOLECULAR SEQUENCE DATA;

EID: 23344449309     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2005.00290.x     Document Type: Review

References (190)

1. Besredka A. De la vaccination contre les etats typhoides par la voie buccale. Ann Inst Pasteur 1919;33:882-903.
2. Davies A. An investigation into the serological properties of dysentery stools. Lancet 1922;2:1009-1012.
3. Francis T Jr, Brightman IJ. Virus-inactivating capacity of nasal secretions in the acute and convalescent stages of influenza. Proc Soc Exp Biol Med 1941;48:116-117.
4. Fazekas de St. Groth S, Donelley M. Studies in experimental immunology of influenza IV. The protective value of active immunization. Aust J Exp Biol Med Sci 1950;28:45-60.
5. Ehrlich P. Ueber Immunitat durch Vererbung und Saugung. Zeitschr f Hyg u Infekt -Krankh 1892;12:183-203.
6. Gugler E, von Muralt G. Ueber immunoelektrophoretische Untersuchungen an Frauenmilch-Proteinen. 2. Schweiz Med Wochenschr 1959;89:925-929.
7. Hanson LÅ. Comparative immunological studies of the immune globulins of human milk and of blood serum. Int Archs Allergy Appl Immun 1961;18:241-267.
8. Mestecky J, Moro I, Kerr MA, Woof JM. Mucosal immunoglobulins. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd edn. Amsterdam: Elsevier/Academic Press 2005:153-181.
9. Jackson S, Mestecky J, Moldoveanu Z, Spearmean P. Appendix I: Collection and processing of human mucosal secretions. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd edn. Amsterdam: Elsevier/Academic Press, 2005:1829-1839.
10. Koshland ME. The coming of age of the immunoglobulin J chain. Ann Rev Immunol 1985;3:425-453.
11. Zikan J, Mestecky J, Kulhavy R, Bennett JC. The stoichiometry of J chain in human secretory dimeric IgA. Mol Immunol 1986;23:541-544.
12. Natvig IB, Johansen F-E, Nordeng TW, Haraldsen G, Brandtzaeg P. Mechanism for enhanced external transfer of dimeric IgA over pentameric IgM. Studies of diffusion, binding to the human polymeric Ig receptor, and epithelial transcytosis. J Immunol 1997;159:4330-4340.
13. Cunningham-Rundles C. Immunodeficiency and mucosal immunity. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd edn. Amsterdam: Elsevier/Academic Press, 2005:1145-1157.
14. Kutteh WH, Mestecky J, Wira CR. Mucosal immunity in the human female reproductive tract. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd edn. Amsterdam: Elsevier/Academic Press, 2005:1631-1646.
15. Peppard JV, Kaetzel CS, Russell MW. Phylogeny and comparative physiology of IgA. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd edn. Amsterdam: Elsevier/Academic Press, 2005:195-208.
16. Mestecky J, Blumberg RS, Kiyono H, McGhee JR. The mucosal immune system. In: Paul WE, ed. Fundamental Immunology, 5th edn. Philadelphia: Lippincott-Raven, 2003:965-1020.
17. Brandtzaeg P. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 2005;206:32-63.
18. Kaetzel CS. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev 2005;206:83-99.
19. Conley ME, Delacroix DL. Intravascular and mucosal immunoglobulin A: Two separate but related systems of immune defense? Ann Intern Med 1987;106:892-899.
20. Mestecky J, Lue C, Russell MW. Selective transport of IgA: cellular and molecular aspects. Gastroenterol Clin North Amer 1991;20:441-471.
21. Russell MW, Kilian M. Biological activities of IgA. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd edn. Amsterdam: Elsevier/Academic Press, 2005:267-289.
22. Russell MW, Mestecky J. Humoral immune responses to microbial infections in the genital tract. Microbes Infect 2002;4:667-677.
23. Boyaka PN, McGhee JR, Czerkinsky C, Mestecky J. Mucosal vaccines: An overview. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd edn. Amsterdam: Elsevier/Academic Press, 2005:855-873.
24. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Human secretory immunoglobulins. I. Salivary secretions from individuals with normal or low levels of serum immunoglobulins. Scand J Immunol 1970;S12:3-83.
25. Zikan J, Mestecky J, Schrohenloher RE, Tomana M, Kulhavy R. Studies on human secretary immunoglobulin A. V. Trypsin hydrolysis at elevated temperatures. Immunochemistry 1972;9:1185-1193.
26. Halpern MS, Koshland ME. The stoichiometry of J chain in human secretory IgA. J Immunol 1973;111:1653-1660.
27. Kutteh WH, Prince SJ, Phillips JO, Spenny JG, Mestecky J. Properties of immunoglobulin A in serum of individuals with liver diseases and in hepatic bile. Gastroenterology 1982;82:184-193.
28. Kutteh WH, Moldoveanu Z, Prince SJ, Kulhavy R, Alonso F, Mestecky J. Biosynthesis of J-chain in human lymphoid cells producing immunoglobulins of various isotypes. Mol Immunol 1983;20:967-976.
29. Delacroix DL, Vaerman J-P. Function of the human liver in IgA homeostasis in plasma. Ann NY Acad Sci 1983;409:383-401.
30. Svanborg Edén C, Kulhavy R, Mårild S, Prince SJ, Mestecky J. Urinary immunoglobulins in healthy individuals and children with acute pyelonephritis. Scand J Immunol 1985;21:305-313.
31. Brandtzaeg P. The role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man. Scand J Immunol 1985;22:111-146.
32. Mestecky J, McGhee JR. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 1987;40:153-245.
33. Brewer JW, Corley RB. Late events in assembly determine the polymeric structure and biological activity of secretory IgM. Mol Immunol 1997;34:323-331.
34. Mestecky J, Kulhavy R, Kraus FW. Studies on human secretory immunoglobulin A. II. Subunit structure. J Immunol 1972;108:738-747.
35. Bastian A, Kratzin H, Eckart K, Hilschmann N. Intra- and interchain disulfide bridges of the human J chain in secretory immunoglobulin A. Biol Chem Hoppe Seyler 1992;373:1255-1263.
36. Krugmann S, Pleass RJ, Atkin JD, Woof JM. Structural requirements for assembly of dimeric IgA probed by site-directed mutagenesis of J chain and a cysteine residue of the α-chain CH2 domain. J Immunol 1997;159:244-249.
37. Underdown BJ, Dorrington KJ. Studies on the structural and conformational basis for the relative resistance of serum and secretory immunoglobulin A to proteolysis. J Immunol 1974;112:949-959.
38. Lindh E. Increased resistance of immunoglobulin A dimers to proteolytic degradation after binding of secretory component. J Immunol 1975;114:284-286.
39. 2: a possible implication for mucosal defense. J Immunol 1998;161:5445-5453.
40. Radl J, Klein F, van den Berg P, de Bruyn AM, Hijmans W. Binding of secretory piece to polymeric IgA and IgM paraproteins in vitro. Immunology 1971;20:843-852.
41. Weicker J, Underdown BJ. A study of the association of human secretory component with IgA and IgM proteins. J Immunol 1975;114:1337-1344.
42. Brandtzaeg P. Transport models for secretory IgA and secretory IgM. Clin Exp Immunol 1981;44:221-232.
43. Vaerman JP, Langendries A, Giffroy D, Brandtzaeg P, Kobayashi K. Lack of SC/pIgR-mediated epithelial transport of a human polymeric IgA devoid of J chain: in vitro and in vivo studies. Immunology 1998;95:90-96.
44. Mestecky J, Kulhavy R, Wright GP, Tomana M. Studies on human secretory immunoglobulin A. VI. Cyanogen bromide cleavage. J Immunol 1974;113:404-412.
45. Mostov KE, Friedlander M, Blobel G. The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains. Nature 1984;308:37-43.
46. Zikan J, et al. Secondary structure of the immunoglobulin J chain. Proc Natl Acad Sci USA 1985;82:5905-5909.
47. Hamburger AE, West AP, Bjorkman PJ. Crystal structure of a polymeric immunoglobulin binding fragment of the human polymeric immunoglobulin receptor. Structure 2004;12:1925-1935.
48. Frutiger S, Hughes GJ, Hanly WC, Kingzette M, Jaton JC. The amino terminal domain of rabbit secretory component is responsible for noncovalent binding to immunoglobulin A dimers. J Biol Chem 1986;261:16673-16681.
49. Bakos M-A, Kurosky A, Goldblum RM. Characterization of a critical binding site for human polymeric Ig on secretory component. J Immunol 1991;147:3419-3426.
50. Hexham JM, et al. A human immunoglobulin (Ig)A Cα3 domain motif directs polymeric Ig receptor-mediated secretion. J Exp Med 1999;189:747-751.
51. Garcia-Pardo A, Lamm ME, Plaut AJ, Frangione B. Secretory component is covalently bound to a single subunit in human secretory IgA. Mol Immunol 1979;16:477-482.
52. Fallgren-Gebauer E, et al. The covalent linkage of the secretory component to IgA. Adv Exp Med Biol 1995;371A:625-628.
53. Braathen R, Sorensen V, Brandtzaeg P, Sandlie I, Johansen FE. The carboxyl-terminal domains of IgA and IgM direct isotype-specific polymerization and interaction with the polymeric immunoglobulin receptor. J Biol Chem 2002;277:42755-42762.
54. Geneste C, Iscaki S, Mangalo R, Pillot J. Both Fc alpha domains of human IgA are involved in in vitro interaction between secretory component and dimeric IgA. Immunol Lett 1986;13:221-226.
55. Johansen FE, Braathen R, Brandtzaeg P. Role of J chain in secretory immunoglobulin formation. Scand J Immunol 2000;52:240-248.
56. Hendrickson BA, et al. Lack of association of secretory component with IgA in J chain-deficient mice. J Immunol 1996;157:750-754.
57. Low TL, Liu YS, Putnam FW. Structure, function, and evolutionary relationships of Fc domains of human immunoglobulins A, G, M, and E. Science 1976;191:390-392.
58. Mestecky J, Schrohenloher RE, Kulhavy R, Wright GP, Tomana M. Site of J chain attachment to human polymeric IgA. Proc Natl Acad Sci USA 1974;71:544-548.
59. Mestecky J, Schrohenloher RE. Site of attachment of J chain to human immunoglobulin M. Nature 1974;249:650-652.
60. Chintalacharuvu KR, Yu LJ, Bhola N, Kobayashi K, Fernandez CZ, Morrison SL. Cysteine residues for the attachment of the light chain in human IgA2. J Immunol 2002;169:5072-5077.
61. Atkin JD, Pleass RJ, Owens RJ, Woof JM. Mutagenesis of the human IgA 1 heavy chain tailpiece that prevents dimer assembly. J Immunol 1996;157:156-159.
62. Sørensen V, Rasmussen IB, Norderhaug L, Natvig I, Michaelsen TE, Sandlie I. Effect of the IgM and IgA secretory tailpieces on polymerization and secretion of IgM and IgG. J Immunol 1996;156:2858-2865.
63. Sørensen V, Sundvold V, Michaelsen TE, Sandlie I. Polymerization of IgA and IgM: roles of Cys309/Cys414 and the secretory tailpiece. J Immunol 1999;162:3448-3455.
64. Tomana M, Niedermeier W, Mestecky J, Skvaril F. The differences in carbohydrate composition between the subclasses of IgA immunoglobulins. Immunochemistry 1976;13:325-328.
65. Torano A, Tsuzukida Y, Liu YV, Putnam FW. Location and structural significance of the oligosaccharides in human IgA1 and IgA2 immunoglobulins. Proc Natl Acad Sci USA 1977;74:2301-2305.
66. Endo T, Mestecky J, Kulhavy R, Kobata A. Carbohydrate heterogeneity of human myeloma proteins of the IgA1 and IgA2 subclasses. Mol Immunol 1994;31:1415-1422.
67. Mattu TS, et al. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. J Biol Chem 1998;273:2260-2272.
68. Royle L, et al. Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J Biol Chem 2003;278:20140-20153.
69. Field MC, Amatayakul-Chantler S, Rademacher TW, Rudd PM, Dwek RA. Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Biochem J 1994;299:261-275.
70. Tomana M, Mestecky J, Niedermeier W. Studies on human secretory immunoglobulins A IV. Carbohydrate composition. J Immunol 1972;108:1631-1636.
71. Mizoguchi A, Mizuochi T, Kobata A. Structures of the carbohydrate moieties of secretory component purified from human milk. J Biol Chem 1982;257:9612-9621.
72. Niedermeier W, Tomana M, Mestecky J. The carbohydrate composition of J chain from human serum and secretory IgA. Biochim Biophys Acta 1972;257:527-530.
73. Baenziger JU. Structure of the oligosaccharide of human J chain. J Biol Chem 1979;254:4063-4071.
74. Mestecky J, Russell MW. IgA Subclasses. Monogr Allergy 1986;19:277-301.
75. Kawamura S, Saitou N, Ueda S. Concerted evolution of the primate immunoglobulin α-gene through gene conversion. J Biol Chem 1992;267:7359-7367.
76. Burnett RC, Hanly WC, Zhai SK, Knight KL. The IgA heavy-chain gene family in rabbit: cloning and sequence analysis of 13 Cα genes. EMBO J 1989;8:4041-4047.
77. Skvaril F, Morell A. Distribution of IgA subclasses in sera and bone marrow plasma cells of 21 normal individuals. Adv Exp Med Biol 1974;45:433-435.
78. Crago SS, et al. Distribution of IgA1-, IgA2- and J chain-containing cells in human tissues. J Immunol 1984;132:16-18.
79. Alley CD, Nash GS, MacDermott RP. Marked in vitro spontaneous secretion of IgA by human rib bone marrow mononuclear cells. J Immunol 1982;128:2604-2608.
80. Hijmans W. Circulating IgA in humans. Adv Exp Med Biol 1987;216B:1169-1174.
81. Kett K, Brandtzaeg P, Radl J, Haaijman JJ. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol 1986;136:3631-3635.
82. Mestecky J, et al. Comparative studies of the biological properties of human IgA subclasses. Protides Biol Fluids 1989;36:173-182.
83. Brown TA, Mestecky J. Immunoglobulin A subclass distribution of naturally occurring salivary antibodies to microbial antigens. Infect Immun 1985;49:459-462.
84. Kobayashi K, Vaerman J-P, Bazin H, Lebacq-Verheyden A-M, Heremans JF. Identification of J-chain in polymeric immunoglobulins from a variety of species by cross-reaction with rabbit antisera to human J-chain. J Immunol 1973;111:1590-1594.
85. Mikoryak CA, Margolies MN, Steiner LA. J chain in Rana catesbiana high molecular weight Ig. J Immunol 1988;140:4279-4285.
86. Kulseth MA, Rogne S. Cloning and characterization of the bovine immunoglobulin J chain cDNA and its promoter region. DNA Cell Biol 1994;13:37-42.
87. Hohman VS, Stewart SE, Willett CE, Steiner LA. Sequence and expression pattern of J chain in the amphibian, Xenopus laevis. Mol Immunol 1997;34:995-1002.
88. Hohman VS, et al. J chain in the nurse shark: implications for function in a lower vertebrate. J Immunol 2003;170:6016-6023.
89. Max EE, Korsmeyer SJ. Human J chain gene. Structure and expression in lymphoid cells. J Exp Med 1985;161:832-849.
90. Frutiger S, Hughes GJ, Paquet N, Luthy R, Jaton JC. Disulfide bond assignment in human J chain and its covalent pairing with immunoglobulin M. Biochemistry 1992;31:12643-12647.
91. Kaetzel CS, Mostov K. Immunoglobulin transport and the polymeric immunoglobulin receptor. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd Edn. Amsterdam: Elsevier/Academic Press, 2005:211-250.
92. Wold A, et al. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect Immun 1990;58:3073-3077.
93. Schroten H, Stapper C, Plogmann R, Köhler H, Hacker J, Hanisch F-G. Fab-independent antiadhesion effects of secretory immunoglobulin A on S-fimbriated Escherichia coli are mediated by sialyloligosaccharides. Infect Immun 1998;66:3971-3973.
94. Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corthesy B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity 2002;17:107-115.
95. Parkhouse RME. Immunoglobulin A biosynthesis. Intracellular accumulation of 7S subunits. FEBS Lett 1971;16:71.
96. Buxbaum JN, Zolla S, Scharff MD, Franklin EC. The synthesis and assembly of immunoglobulins by malignant human plasmocytes III. Heterogeneity of IgA polymer assembly. Eur J Immunol 1974;4:367.
97. Kutteh WH, Prince SJ, Mestecky J. Tissue origins of human polymeric and monomeric IgA. J Immunol 1982;128:990-995.
98. Moldoveanu Z, Egan ML, Mestecky J. Cellular origins of human polymeric and monomeric IgA: intracellular and secreted forms of IgA. J Immunol 1984;133:3156-3162.
99. Radl J, Schuit HRE, Mestecky J, Hijmans W. The origin of monomeric and polymeric forms of IgA in man. Adv Exp Med Biol 1974;45:57-65.
100. Brandtzaeg P. Two types of IgA immunocytes in man. Nat New Biol 1973;243:142-143.
101. Brandtzaeg P. Immunohistochemical characterization of intracellular J chain and binding site for secretory component (SC) in human immunoglobulin (Ig)-producing cells. Mol Immunol 1983;20:941-966.
102. Moro I, Iwase T, Komiyama K, Moldoveanu Z, Mestecky J. Immunoglobulin A (IgA) polymerization sites in human immunocytes: immunoelectron microscopic study. Cell Struct Funct 1990;15:85-91.
103. Hendrickson BA, et al. Altered hepatic transport of immunoglobulin A in mice lacking the J chain. J Exp Med 1995;182:1905-1911.
104. Lycke N, Erlandsson L, Ekman L, Schön K, Leanderson T. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection. J Immunol 1999;163:913-919.
105. Erlandsson L, Andersson K, Sigvardsson M, Lycke N, Leanderson T. Mice with an inactivated joining chain locus have perturbed IgM secretion. Eur J Immunol 1998;28:2355-2365.
106. Erlandsson L, Akerblad P, Vingsbo-Lundberg C, Kallberg E, Lycke N, Leanderson T. Joining chain-expressing and -nonexpressing B cell populations in the mouse. J Exp Med 2001;194:557-570.
107. Munn EA, Feinstein A, Munro AJ. Electron microscope examination of free IgA molecules and of their complexes with antigen. Nature 1971;231:527-529.
108. Dourmashkin RR, Virella G, Parkhouse RME. Electron microscopy of human and mouse myeloma serum IgA. J Mol Biol 1971;56:207-208.
109. Feinstein A, Munn E, Richardson N. The three-dimensional conformation of γM and γA globulin molecules. Ann NY Acad Sci 1971;190:104-121.
110. Zagyansky YA, Gavrilova EM. Segmental flexibility of human myeloma immunoglobulin A. Immunochemistry 1974;11:681-682.
111. Dudich EI, Dudich IV, Timofeev VP. Fluorescence polarization and spin-label study of human myeloma immunoglobulins A and M. Presence of segmental flexibility. Mol Immunol 1980;17:1335-1339.
112. Liu BM, Cheung HC, Mestecky J. Nanosecond fluorescence spectroscopy of human immunoglobulin A. Biochemistry 1981;20:1997-2003.
113. Boehm MK, Woof JM, Kerr MA, Perkins SJ. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling. J Mol Biol 1999;286:1421-1447.
114. Furtado PB, et al. Solution structure determination of monomeric human IgA2 by X-ray and neutron scattering, analytical ultracentrifugation and constrained modelling: a comparison with monomeric human IgA1. J Mol Biol 2004;338:921-941.
115. Herr AB, Ballister ER, Bjorkman PJ. Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc. Nature 2003;423:614-620.
116. Prahl JW, Abel CA, Grey HM. Carboxyterminal structure of the α chain of human IgA myeloma proteins. Biochemistry 1971;10:1808-1812.
117. Bakos MA, Kurosky A, Czerwinski EW, Goldblum RM. A conserved binding site on the receptor for polymeric Ig is homologous to CDR1 of Ig V kappa domains. J Immunol 1993;151:1346-1352.
118. Coyne RS, Siebrecht M, Peitsch MC, Casanova JE. Mutational analysis of polymeric immunoglobulin receptor/ligand interactions. Evidence for the involvement of multiple complementarity determining region (CDR) -like loops in receptor domain I. J Biol Chem 1994;269:31620-31625.
119. Norderhaug IN, Johansen FE, Krajci P, Brandtzaeg P. Domain deletions in the human polymeric Ig receptor disclose differences between its dimeric IgA and pentameric IgM interaction. Eur J Immunol 1999;29:3401-3409.
120. Rejnek J, Trávnícek J, Kostka J, Sterzl J, Lanc A. Study of the effect of antibodies in the intestinal tract of germ-free baby pigs. Folia Microbiol 1968;13:36-42.
121. Mestecky J, Russell MW. Intestinal immunoglobulin A: role in host defense. In: Hecht G, ed. Microbial Pathogens and the Intestinal Epithelial Cell. Washington, DC: ASM Press, 2003:95-112.
122. Russell MW, Sibley DA, Nikolova EB, Tomana M, Mestecky J. IgA antibody as a non-inflammatory regulator of immunity. Biochem Soc Trans 1997;25:466-470.
123. Brandtzaeg P, Tolo K. Mucosal penetrability enhanced by serum-derived antibodies. Nature 1977;266:262-263.
124. Savage DG. Mucosal microbiota. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd edn. Amsterdam: Elsevier/Academic Press, 2005:19-33.
125. Abraham SN, Bishop BL, Sharon N, Ofek I. Adhesion of bacteria to mucosal surfaces. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd edn. Amsterdam: Elsevier/Academic Press, 2005:35-48.
126. Renegar KB, Jackson GD, Mestecky J. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J Immunol 1998;160:1219-1223.
127. Stubbe H, Berdoz J, Kraehenbuhl JP, Corthesy B. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J Immunol 2000;164:1952-1960.
128. Mazanec MB, Coudret CL, Fletcher DR. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 1995;69:1339-1343.
129. Bomsel M, et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity 1998;9:277-287.
130. Russell MW, Bobek LA, Brock JH, et al. Innate humoral defense factors. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Stober W, eds. Mucosal Immunology, 3rd edn. Amsterdam: Elsevier/Academic Press, 2005:73-93.
131. Biesbrock AR, Reddy MS, Levine MJ. Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect Immun 1991;59:3492-3497.
132. Magnusson KE, Stjernstrom I. Mucosal barrier mechanisms. Interplay between secretory IgA (SIgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes. Immunology 1982;45:239-248.
133. Russell MW, Reinholdt J, Kilian M. Anti-inflammatory activity of human IgA antibodies and their Fabα fragments: inhibition of IgG-mediated complement activation. Eur J Immunol 1989;19:2243-2249.
134. Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 2001;167:2861-2868.
135. Woof JM, van Egmond M, Kerr MA. Fc receptors. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd. Edn. Amsterdam: Elsevier/Academic Press, 2005:251-265.
136. Hamre R, Farstad IN, Brandtzaeg P, Morton HC. Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the Fc γ chain on myeloid cells in blood and tissue. Scand J Immunol 2003;57:506-516.
137. Kremer EJ, Kalatzis V, Baker E, Callen DF, Sutherland GR, Maliszewski CR. The gene for the human IgA Fc receptor maps to 19q13.4. Hum Genet 1992;89:107-108.
138. Woof JM, Kerr MA. IgA function - variations on a theme. Immunology 2004;113:175-177.
139. Morton HC, et al. Cloning and characterization of an IgA Fc receptor from cattle (bFcαR). Immunology 2004;111:204-211.
140. Morton HC, Pleass RJ, Storset AK, Brandtzaeg P, Woof JM. Cloning and characterization of equine CD89 and identification of the CD89 gene in chimpanzees, and rhesus macaques. Immunology 2005;115:74-84.
141. Rogers KA, Scinicariello F, Attanasio R. Identification and characterization of macaque CD89 (immunoglobulin A Fc receptor). Immunology 2004;113:178-186.
142. Maliszewski CR, March CJ, Schoenborn MA, Gimpel S, Shen L. Expression cloning of a human Fc receptor for IgA. J Exp Med 1990;172:1665-1672.
143. Ding Y, et al. Crystal structure of the ectodomain of human FcαRI. J Biol Chem 2003;278:27966-27970.
144. Carayannopoulos L, Hexham JM, Capra JD. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Cα2 and Cα3 in human IgA1. J Exp Med 1996;183:1579-1586.
145. Pleass RJ, Dunlop JI, Anderson CM, Woof JM. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human Fcα receptor (FcαR) CD89. J Biol Chem 1999;274:23508-23514.
146. Pleass RJ, Dehal PK, Lewis MJ, Woof JM. Limited role of charge matching in the interaction of human immunoglobulin A with the immunoglobulin A Fc receptor (FcαRI) CD89. Immunology 2003;109:331-335.
147. Wines BD, Hulett MD, Jamieson GP, Trist HM, Spratt JM, Hogarth PM. Identification of residues in the first domain of human Fcα receptor essential for interaction with IgA. J Immunol 1999;162:2146-2153.
148. Morton HC, van Zandbergen G, van Kooten C, Howard CJ, van de Winkel JG, Brandtzaeg P. Immunoglobulin-binding sites of human FcαRI (CD89) and bovine Fcγ2R are located in their membrane-distal extracellular domains. J Exp Med 1999;189:1715-1722.
149. Wines BD, Sardjono CT, Trist HH, Lay CS, Hogarth PM. The interaction of FcαRI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J Immunol 2001;166:1781-1789.
150. Herr AB, White CL, Milburn C, Wu C, Bjorkman PJ. Bivalent binding of IgA1 to FcαRI suggests a mechanism for cytokine activation of IgA phagocytosis. J Mol Biol 2003;327:645-657.
151. Woof JM, Burton DR. Human antibody-Fc receptor interactions illuminated by crystal structures. Nat Rev Immunol 2004;4:89-99.
152. Weisbart RH, Kacena A, Schuh A, Golde DW. GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 1988;332:647-648.
153. Bracke M, et al. Differential effects of the T helper cell type 2-derived cytokines IL-4 and IL-5 on ligand binding to IgG and IgA receptors expressed by human eosinophils. J Immunol 1997;159:1459-1465.
154. van Egmond M, et al. FcαRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med 2000;6:680-685.
155. Stewart WW, Kerr MA. The specificity of the human neutrophil IgA receptor (FcαR) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2. Immunology 1990;71:328-334.
156. van Spriel AB, et al. Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunological synapse formation. Blood 2001;97:2478-2486.
157. van Spriel AB, Leusen JH, Vile H, van de Winkel JG. Mac-1 (CD11b/CD18) as accessory molecule for FcαR (CD89) binding of IgA. J Immunol 2002;169:3831-3836.
158. Lang ML, Shen L, Wade WF. γ-chain dependent recruitment of tyrosine kinases to membrane rafts by the human IgA receptor FcαR. J Immunol 1999;163:5391-5398.
159. Lang ML, et al. IgA Fc receptor (FcαR) cross-linking recruits tyrosine kinases, phosphoinositide kinases and serine/threonine kinases to glycolipid rafts. Biochem J 2002;364:517-525.
160. Monteiro RC, van de Winkel JGJ. IgA Fc receptors. Annu Rev Immunol 2003;21:177-204.
161. van Egmond M, et al. Human immunoglobulin A receptor (FcαRI, CD89) function in transgenic mice requires both FcR γ chain and CR3 (CD11b/CD18). Blood 1999;93:4387-4394.
162. Pasquier B, et al. Identification of FcαRI as an inhibitory receptor that controls inflammation: dual role of Fcγ ITAM. Immunity 2005;22:31-42.
163. Shibuya A, et al. Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nat Immunol 2000;1:441-446.
164. Sakamoto N, et al. A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues. Eur J Immunol 2001;31:1310-1316.
165. Nakahara J, Seiwa C, Shibuya A, Aiso S, Asou H. Expression of Fc receptor for immunoglobulin M in oligodendrocytes and myelin of mouse central nervous system. Neurosci Lett 2003;337:73-76.
166. Shimizu Y, et al. Fcα/μ receptor is a single gene-family member closely related to polymeric immunoglobulin receptor encoded on Chromosome 1. Immunogenetics 2001;53:709-711.
167. Kita H, et al. Does IgE bind to and activate eosinophils from patients with allergy? J Immunol 1999;162:6901-6911.
168. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989;142:2392-2400.
169. Monteiro RC, Hostoffer RW, Cooper MD, Bonner JR, Gartland GL, Kubagawa H. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 1993;92:1681-1685.
170. Lamkhioued B, Gounni AS, Gruart V, Pierce A, Capron A, Capron M. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation. Eur J Immunol 1995;25:117-125.
171. Motegi Y, Kita H. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. J Immunol 1998;161:4340-4346.
172. Monteiro RC, et al. Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol Med 2002;8:464-468.
173. Moura IC, et al. Identification of the transferrin receptor as a novel immunoglobulin (Ig) A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001;194:417-425.
174. Haddad E, et al. Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schönlein nephritis: association between CD71 expression and IgA deposits. J Am Soc Nephrol 2003;14:327-337.
175. Pasquier B, Lepelletier Y, Baude C, Hermine O, Monteiro RC. Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells. J Leukoc Biol 2004;76:1134-1141.
176. Quan CP, Berneman A, Pires R, Avrameas S, Bouvet JP. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 1997;65:3997-4004.
177. Dunn-Walters D, Boursier L, Spencer J. Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions. Mol Immunol 2000;37:107-113.
178. Fernandez C, Alarcon-Riquelme ME, Abedi-Valugerdi M, Sverremark E, Cortes V. Polyreactive binding of antibodies generated by polyclonal B cell activation. I. Polyreactivity could be caused by differential glycosylation of immunoglobulins. Scand J Immunol 1997;45:231-239.
179. Fernandez C, Alarcon-Riquelme ME, Sverremark E. Polyreactive binding of antibodies generated by polyclonal B cell activation. II. Crossreactive and monospecific antibodies can be generated from an identical Ig rearrangement by differential glycosylation. Scand J Immunol 1997;45:240-247.
180. Kilian M, Russell MW. Microbial evasion of IgA functions. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology, 3rd edn. Amsterdam: Elsevier/Academic Press, 2005:291-303.
181. Senior BW, Dunlop JI, Batten MR, Kilian M, Woof JM. Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases. Infect Immun 2000;68:463-469.
182. Batten MR, Senior BW, Kilian M, Woof JM. Amino acid sequence requirements in the hinge of human immunoglobulin A1 (IgA1) for cleavage by streptococcal IgA1 proteases. Infect Immun 2003;71:1462-1469.
183. Senior BW, Woof JM. Effect of mutations in the human immunoglobulin A1 (IgA1) hinge on its susceptibility to cleavage by diverse bacterial IgA1 proteases. Infect Immun 2005;73:1515-1522.
184. Senior BW, Woof JM. The influences of hinge length and composition on the susceptibility of human IgA to cleavage by diverse bacterial IgA1 proteases. J Immunol 2005;174:7792-7799.
185. Chintalacharuvu KR, et al. Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA. Infect Immun 2003;71:2563-2570.
186. Frithz E, Héden L-O, Lindahl G. Extensive sequence homology between IgA receptor and M proteins in Streptococcus pyogenes. Mol Microbiol 1989;3:1111-1119.
187. Stenberg L, O'Toole PW, Mestecky J, Lindahl G. Molecular characterization of protein Sir, a streptococcal cell surface protein that binds both immunoglobulin A and immunoglobulin G. J Biol Chem 1994;269:13458-13464.
188. Héden L-O, Frithz E, Lindahl G. Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur J Immunol 1991;21:1481-1490.
189. Jerlström PG, Chhatwal GS, Timmis KN. The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions. Mol Microbiol 1991;5:843-849.
190. Pleass RJ, Areschoug T, Lindahl G, Woof JM. Streptococcal IgA-binding proteins bind in the Cα2-Cα3 interdomain region and inhibit binding of IgA to human CD89. J Biol Chem 2001;276:8197-8204.